BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Praxair Announces Price Increases Effective January 1, 2018

  These adjustments are in response to rising energy, distribution and labor costs.

  December 15, 2017

   · 

  1 min read
• Pharm Country

  Pfizer Inc. Announces Expiration and Results of Its Private Exchange Offer for Its 6.500 Per Cent. Notes Due 2038 and Related Tender Offer

  Pfizer announced the expiration and results of its previously announced offers to exchange and to repurchase any and all of its outstanding £1,500,000,000 6.500 per cent.

  December 15, 2017

   · 

  11 min read
• Biotech Beach

  CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

  ViaCyte today announced that the CIRM approved a grant of $1.4M to support the initial development of immune-evasive pluripotent stem cell lines.

  December 15, 2017

   · 

  4 min read
• Business

  Elekta Collaborates With Palabra to Offer the Industry’s Only Voice-Enabled EHR

  The integrated system has been installed in sites in North America and Australia.

  December 15, 2017

   · 

  2 min read
• 

  Deals

  Siemens Healthineers Scoops Up 80-Employee Fast Track Diagnostics for Undisclosed Sum

  The acquisition increases the menu of the Siemens Healthineers VERSANT kPCR Molecular System1 by over 80 assays and syndromic panels.

  December 15, 2017

   · 

  4 min read
• Teva Announces Exclusive Launch of Generic Viread in the United States

  Teva announced the exclusive launch of generic Viread1 (tenofovir disoproxil fumarate) tablets 300 mg in the U.S.

  December 15, 2017

   · 

  9 min read
• Business

  Dr. Sally Ann Forsyth Appointed CEO of Stevenage Bioscience Catalyst

  With scientific and financial expertise and as an open innovation practitioner, Forsyth will lead SBC through its next phase of expansion.

  December 15, 2017

   · 

  2 min read
• Business

  Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations

  Mackenzie will be responsible for leadership of Aquinox’s functions of research, including preclinical operations, chemistry, manufacturing, and controls, quality assurance, and clinical operations.

  December 15, 2017

   · 

  6 min read
• Policy

  Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

  If approved, Burosumab would be the first targeted disease-modifying treatment for XLH.

  December 15, 2017

   · 

  7 min read
• Genetown

  Mersana Therapeutics Added to NASDAQ Biotechnology Index

  Mersana’s addition to the NBI will become effective prior to market open on Monday, December 18th, 2017.

  December 15, 2017

   · 

  3 min read